http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003176698-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2000-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_299aa2eaeffd7f35fffe806fbe77b18a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d66dcbbf405fbb084af2e3a632fb27e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ad42ce508d41c29bef6ffb7d94471d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5924afb5f2db2e5c6616ae48743fe98f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0898d69656e2ecc8127c68f0c8e937a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c29400c3688916731e0d67f12f69f85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e877bd4ae0ad2a355b80cb1acfa43cd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff7505487b5b824a7cb45833a4fd00b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2489a1d0c78baa21f30fb2ef99e48c52 |
| publicationDate | 2003-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003176698-A1 |
| titleOfInvention | Fused purine derivatives |
| abstract | A condensed purine derivative represented by Formula (I): n n n wherein X—Y—Z represents R 1 N—C═O or N═C—W, R 2 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted alicyclic heterocyclic group or the like, n represents an integer of from 0 to 3, V 1 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aromatic heterocyclic group, V 2 represents a substituted lower alkyl group or a substituted or unsubstituted aromatic heterocyclic group, and when V 1 represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group, and for example, X—Y—Z represents R 1a N—C═O and R 2 represents a substituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted alicyclic heterocyclic group, a halogen atom, a lower alkylthio group, —NR 7 R 8 , —CO 2 H, a lower alkoxycarbonyl group, —COHal, —CONR 9 R 10 or —CHO, V 2 may represent a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group; or a pharmacologically acceptable salt thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007191402-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007249597-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003220358-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006252780-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546368-B2 |
| priorityDate | 1999-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1657.